541 results about "Therapeutic Area" patented technology

A device, a system and a method for contracting tissue in a mammalian body. The contracting device comprises a body and a plurality of legs radially splayed there from. Each leg includes a snap-acting spring tip. When a force is applied to the device, the tips operate to transform the device from a deployment state into a treatment state. Each leg may also be bent at one or more deformation elements in response to the application of force. The system comprises a contracting device slidably received within a delivery catheter. The method of contracting tissue in a mammalian body comprises delivering a contracting device in a lumen of a catheter proximate a treatment area, releasing the contracting device from the catheter, positioning legs of the contracting device on tissue to be contracted, exerting a force on the contracting device, transforming the device into a treatment state, and reducing a compass of the tissue in response to the attainment of the treatment state.

An ultrasonic system useful for providing imaging, therapy and temperature monitoring generally comprises an acoustic transducer assembly configured to enable the ultrasound system to perform the imaging, therapy and temperature monitoring functions. The acoustic transducer assembly comprises a single transducer that is operatively connected to an imaging subsystem, a therapy subsystem and a temperature monitoring subsystem. The ultrasound systems may also include a display for imaging and temperature monitoring functions. An exemplary single transducer is configured such that when connected to the subsystems, the imaging subsystem can generate all image of a treatment region on the display, the therapy subsystem can generate high power acoustic energy to heat the treatment region, and the temperature monitoring subsystem can map and monitor the temperature of the treatment region and display the temperature on the display, an through the use of the single transducer. Moreover, the acoustic transducer assembly is configured such that the imaging, therapeutic heating and temperature monitoring of the treatment region can be conducted substantially simultaneously.

A system for treating a target region in tissue beneath a tissue surface comprises a probe for deploying an electrode array within the tissue and a surface electrode for engaging the tissue surface above the treatment site. Preferably, surface electrode includes a plurality of tissue-penetrating elements which advance into the tissue, and the surface electrode is removably attachable to the probe. The tissue may be treated in a monopolar fashion where the electrode array and surface electrode are attached to a common pole on an electrode surgical power supply and powered simultaneously or successively, or in a bipolar fashion where the electrode array and surface electrode are attached to opposite poles of the power supply. The systems are particularly useful for treating tumors and other tissue treatment regions which lie near the surface.

An ultrasonic system useful for providing imaging, therapy and temperature monitoring generally comprises an acoustic transducer assembly configured to enable the ultrasound system to perform the imaging, therapy and temperature monitoring functions. The acoustic transducer assembly comprises a single transducer that is operatively connected to an imaging subsystem, a therapy subsystem and a temperature monitoring subsystem. The ultrasound system may also include a display for imaging and temperature monitoring functions. An exemplary single transducer is configured such that when connected to the subsystems, the imaging subsystem can generate an image of a treatment region on the display, the therapy subsystem can generate high power acoustic energy to heat the treatment region, and the temperature monitoring subsystem can map and monitor the temperature of the treatment region and display the temperature on the display, all through the use of the single transducer. Additionally, the acoustic transducer assembly can be configured to provide three-dimensional imaging, temperature monitoring or therapeutic heating through the use of adaptive algorithms and/or rotational or translational movement. Moreover, a plurality of the exemplary single transducers can be provided to facilitate enhanced treatment capabilities.

A photon therapy unit implement has a flexible head for conforming to a body part to be treated. The head has a thermally conductive backing to remove heat form the treatment area. The operation of the head is monitored by a photon detector to provide a feedback to the diode drive circuit to maintain the output at the required level. Operation of the head is monitored by a microprocessor which performs a diagnostic function and reports on defects. The treatment protocol is generated by a main control unit that formulates a treatment waveform from a set of treatment protocols. The selection of protocols is performed through a graphical user interface (GUI) which allows selection of treatment areas and customization of treatment as well as maintaining patient history and annotations.

A wireless, handheld electrical therapy device delivers electrical pulses to a treatment area of a patient. In one embodiment, the device comprises a microcontroller-based pulse generator circuit selectively operable in a plurality of therapeutic modes. The device comprises an ergonomic housing adapted to be comfortably grasped by a user. A plurality of electrodes are disposed on a surface of the housing. In operation, a user brings the electrodes into contact with a patient's skin at a location on the patient to be treated. Electrical pulses are delivered between the electrodes, thereby electrically stimulating neural tissue at the treatment location. In one embodiment, the device is operable in a manual mode wherein the user selects from among a plurality of therapeutic regimens each corresponding to a set of predetermined operational parameters. Among the variable operational parameters are pulse amplitude, frequency, duration, damping, and shape. In another embodiment of the invention, the device is operable in an automatic mode wherein electrical conditions at the skin surface are periodically sensed and the operational parameters automatically adjusted to achieve optimal therapeutic effectiveness.

A method for treating presbyopia by performing ablative photodecomposition of the corneal surface. The offset image of a variable aperture, such as a variable width slit and variable diameter iris diaphragm, is scanned in a preselected pattern to perform ablative sculpting of predetermined portions of a corneal surface. The scanning is performed to ablate an optical zone sized to match the patient pupil with a peripheral transition zone outside the pupil. The shape of the ablated optical zone is different from the shape of the final optical correction on the anterior surface of the cornea. The optical zone corrects for near-vision centrally and far-vision peripherally. A movable image displacement mechanism enables radial displacement and angular rotation of the profiled beam exiting from the variable aperture. The method enables wide area treatment with a laser having a narrower beam than the treatment area, and can be used in the treatment of many conditions in conjunction with presbyopia such as hyperopia, hyperopic astigmatism and irregular refractive aberrations.

An apparatus and method for ocular surgery includes a delivery system for generating and guiding a surgical laser beam to a focal point on a target surface in a treatment area of an eye. A detector is coupled to the beam path of the surgical laser to create a three-dimensional image of the target surface, and a computer morphs this three-dimensional image into a two-dimensional image. Operationally, the computer then uses the two-dimensional image to position and move the focal point in the treatment area for surgery.

Freeze wells may be used to isolate an area for soil remediation. Freeze wells may form a frozen barrier around a treatment area. The frozen barrier may inhibit fluid from entering into the treatment area. The frozen barrier may also inhibit migration of contamination out of the treatment area. The frozen barrier may be used to surround all of the perimeter of the treatment area. A frozen barrier may also be formed above or below a treatment area. Freeze wells may be activated in advance of soil remediation so that a frozen barrier is formed when soil remediation is begun. The soil remediation may be accomplished by any type of soil remediation system, including a thermal soil remediation system. Heaters of a thermal soil remediation system may be may be placed close to the frozen barrier without the barrier being broken through during remediation.

A method and apparatus are provided for treating biological cellular material with a treating agent using pulsed electrical fields provided by a waveform generator (12). The treatment method includes obtaining an electrode assembly which includes three or more parallel rows of individual electrodes (19). The electrode assembly is applied to a treatment area. Electrically conductive pathways are established between the electrodes (19) and the waveform generator (12) through an array switch (14). Successive electric fields are applied to the treatment area in the form of successive electric field waveforms from the waveform generator (12), through the array switch (14), to adjacent rows of electrodes (19), wherein each successive electric field has the same direction, and wherein polarities of rows of electrodes are reversed successively during the applying of the successive electric fields between adjacent successive rows of electrodes to the treatment area. As a result, the biological cellular material in the treatment area is treated with the treating agent unidirectionally with uniform electric fields with a minimization of the formation of deleterious electrochemistry products at the electrodes.

A system and method for interactively planning and controlling a treatment of a patient for a medical treatment device are provided. The system includes a memory; a processor coupled to the memory; and a treatment control module stored in the memory and executable by the processor. The treatment control module graphically displays in real time a continuously changing treatment region defined by the electrodes as a user moves at least one of the electrodes. This allows the user to more effectively plan and treat a target region.

A method and system for noninvasive face lifts and deep tissue tightening are disclosed. An exemplary method and treatment system are configured for the imaging, monitoring, and thermal injury to treat the SMAS region. In accordance with an exemplary embodiment, the exemplary method and system are configured for treating the SMAS region by first, imaging of the region of interest for localization of the treatment area and surrounding structures, second, delivery of ultrasound energy at a depth, distribution, timing, and energy level to achieve the desired therapeutic effect, and third to monitor the treatment area before, during, and after therapy to plan and assess the results and/or provide feedback.

A delivery device that allows for the sustained release of an agent, particularly useful for the sustained release of a therapeutic agent to limited access regions, such as the posterior chamber of the eye and inner ear. The delivery device is minimally invasive, refillable and may be easily fixed to the treatment area. The delivery device includes a hollow body with an inlet port at its proximal end for insertion of the agent, a reservoir for holding the agent and a delivery mechanism for the sustained delivery of the agent from the reservoir to the patient.

A compound of formula (I) and salts and solvates thereof, in which: R0 represents hydrogen, halogen, or C1-6alkyl; R1 represents hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, haloC1-6alkyl, C3-8cycloalkyl, C3-8cycloalkylC1-3alkyl, arylC1-3alkyl, or heteroarylC1-3alkyl; R2 represents an optionally substituted monocyclic aromatic ring selected from benzene, thiophene, furan, and pyridine, or an optionally substituted bicyclic ring (a) attached to the rest of the molecule via one of the benzene ring carbon atoms, and wherein the fused ring (A) is a 5- or 6-membered ring which may be saturated or partially or fully unsaturated, and comprises carbon atoms and optionally one or two heteroatoms selected from oxygen, sulphur, and nitrogen; and R3 represents hydrogen or C1-3alkyl, or R1 and R3 together represent a 3- or 4-membered alkyl or alkenyl chain. A compound of formula (I) is a potent and selective inhibitor of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase (cGMP specific PDE) having a utility in a variety of therapeutic areas where such inhibition is beneficial, including the treatment of cardiovascular disorders and erectile dysfunction.

The present invention relates to spacers that are configured to promote fusion. Windows or openings in the sidewalls of the fusion spacers may be provided to allow a physician to view the treated area to confirm that fusion has occurred or to check on the progress of treatment. Fusion spacers of the invention may have two or more pairs of openings or windows that allow viewing of the treated area from different perspectives.